|
|
|
| |
|
Timeframe
|
|
|
|
|
Category
|
|
|
| |
|
Sub-Category
|
|
|
|
| ** To make multiple selections, select the first criterion and then press and hold
the Ctrl Key **
|
|
| |
|
1- 17 of 17
Search Results for:
|
Ordering of Search Results
When searching across multiple libraries:
FAQs will appear in alphabetical order by category and sub-category
Listing Council Decisions will appear in reverse chronological order by year.
Staff Interpretations will appear in reverse chronological order by year
When searching using keywords:
Results are returned in order of term frequency (i.e., the number of times the keywords appear in the material).
|
|
Libraries:  
Staff Interpretation Letters
|
|
Filters:  
All Years; Shareholder Approval; Equity Compensation - Exceptions,Equity Compensation - General/Applicability,Equity Compensation - Materiality of Amendments
|
|
|
|
|
Identification Number
1862
|
|
|
This is in response to your correspondence asking whether a proposed “nonqualified” Employee Share Purchase Plan (“Plan”) would require shareholder approval pursuant to Listing Rule 5635(c) (“Rule”).
According to the information you provided, under the Plan, eligible employees would participate by contributing no greater than five percent of their regular salary, wages and commissions (“Employee Contribution”), which the company would match in the applicable payroll period (“Employer Contribution”). The Employee Contribution and Employer Contribution would be used to purchase common shares periodically in the open market at prevailing market prices. The shares will be acquired by an administrator on behalf of Plan participants as fully paid and non-assessable shares, and will be held in an account for the participant maintained by the administrator. Plan participants may elect to receive the shares, or the proceeds from the sale of the shares, with written notice; provided, however, that a participant will be ineligible to receive an Employer Contribution for five years following any such release of shares. Neither the Employee Contribution nor the Employer Contribution will be tax deferred.
Following our review of the information you provided, we have determined that shareholder approval is required prior to the issuance of securities under the Plan. The Rule sets forth the requirement to obtain shareholder approval for equity compensation plans pursuant to which stock may be acquired by certain recipients, including employees of the Company, unless an enumerated exception applies. Exceptions provided in Listing Rules 5635(c)(1), (3), and (4) do not apply under the plain reading of the Rule. Under Rule 5635(c)(2), shareholder approval is not required for certain tax qualified, non-discriminatory employee benefit plans and plans that merely provide a convenient way for participants to purchase shares in the open market or from the company at fair market value in lieu of cash otherwise due to a participant. This is not such a plan because it is “nonqualified” and because the Plan participants receive a defined benefit in a form of an Employer Contribution, which, in economic terms, is equivalent to issuing securities to a participant at a discount to market value. As such, the Plan is an equity compensation arrangement that would require shareholder approval prior to the issuance of securities under the Plan.
|
Publication Date*:
4/24/2023
|
|
|
Identification Number:
1862
|
|
|
|
|
Identification Number
1854
|
|
|
This is in response to your correspondence regarding whether a proposed amendment (the “Amendment”) to the Plan would require shareholder approval pursuant to Listing Rules 5635(c) and IM-5635-1 (collectively, the “Rule”).
According to the information you provided, eligible participants under the Plan include directors, employees, and certain consultants. Awards available for issuance under the Plan are share units which give the participant the right to receive one common share of the company. The Plan provides for three-year vesting schedule with one-third of the award becoming vested annually upon the anniversary of the grant date, subject to terms and conditions the Company may set in its discretion.
Currently, a provision of the Plan prohibits the acceleration of vesting of awards. Pursuant to the Amendment, the board of directors of the Company (the “Board”) will be granted the authority to determine the vesting provisions of the awards issued pursuant to the Plan and to change such provisions, including the authority to accelerate the vesting provisions.
Following our review of the information you provided, we have determined that the Amendment would not be material under the Rule. Generally, a change in the vesting terms for an award is not a material amendment, provided that the change does not result in either an extension in the term of the award beyond the maximum allowable term under the plan or in an addition to the aggregate shares available. The Amendment would not change the Plan in either of the aforementioned ways. Further, other provisions of the Plan permit the issuance of awards that could be subject to accelerated vesting. Accordingly, the Rule does not require shareholder approval for the Amendment.
|
Publication Date*:
11/28/2022
|
|
|
Identification Number:
1854
|
|
|
|
|
Identification Number
1835
|
|
|
This is in response to your correspondence asking if an amendment to a shareholder approved employee stock purchase plan (the “Plan”) removing the term of the Plan, which is currently scheduled to expire in about six months, would require shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”).
You stated that the Plan is intended to qualify as an “employee stock purchase plan” under Section 423 of the Internal Revenue Code of 1986, as amended (the “Code”), and is available for participation by all employees of the Company and certain subsidiaries, subject to limited exceptions to eligibility as permitted under Section 423 of the Code. The Plan became effective approximately nine and a half years ago, following its approval by the shareholders of the Company as required by Section 423 of the Code. The terms of the Plan provide that it will continue in effect for approximately ten years following effectiveness, unless sooner terminated under the terms of the Plan (the “Term”).
You stated that the Company proposes to remove the Term (the “Amendment) but does not intend to increase the total number of shares authorized and available for purchase under the Plan. You stated that the Amendment will be approved by the independent members of the Company’s board of directors but does not require shareholder approval under the terms of the Plan. You also stated that Section 423 of the Code does not require that the Amendment be approved by the Company’s shareholders. Finally, you stated that the Amendment will not affect any of the other material terms of the Plan.
Following our review of the information you provided, we have determined that the Amendment would not require shareholder approval under the Rule because following the Amendment the Plan will continue to be a tax qualified, non-discriminatory employee benefit plan that meets the requirements of Section or 423 of the Code and the Amendment will be approved by the Company's a majority of the Company's independent directors as required by Listing Rule 5635(c)(2).
|
Publication Date*:
5/13/2022
|
|
|
Identification Number:
1835
|
|
|
|
|
Identification Number
1856
|
|
|
This is in response to your correspondence regarding whether a repricing of certain previously granted options, by lowering the exercise price per share, issued under the Plan would require shareholder approval pursuant to Listing Rules 5635(c) and IM-5635-1 (collectively, the “Rule”) (Question 1). Separately, you asked whether Listing Rule 5635(c)(4) permits issuance of awards in reliance on this rule pursuant to an Inducement Plan that was adopted after the awards were offered and accepted by newly hired employees, but not yet issued (Question 2).
Question 1
According to the information you provided, the Plan, which was approved by the Company’s shareholders, authorizes an “Exchange Program” and provides that the plan administrator can determine the terms and conditions of any Exchange Program in its sole discretion, subject to any required shareholder consent. The Plan defines an Exchange Program as a program under which outstanding awards are surrendered or canceled in exchange for awards of the same type (which may have higher or lower exercise prices and different terms), awards of a different type, and/or cash, and further provides that under an Exchange Program the exercise price of an outstanding Award can be increased or reduced. Based on this language, you stated that the Company’s management and the administrator of the Plan, consisting of independent members of the Company’s Board of Directors, each believe that the Plan specifically authorizes a repricing of awards where an exercise price of a previously issued option is reduced. You stated that the Plan’s definition of an Exchange Program includes an action by a Plan administrator to reduce the exercise price of an outstanding award. You further stated that none of the Company’s organizational documents, including certificate of incorporation and bylaws, contracts, or other corporate governance documents require shareholder approval of a repricing, as described above.
Following our review of the information you provided, we have determined that lowering the exercise price per share for previously granted options under the Plan does not require shareholder approval under the Rule because the administrator of the Plan is already specifically authorized to conduct such an action, by the Plan, which was previously approved by the Company’s shareholders, and the Company is not proposing to amend the Plan.
Question 2
Separately, you stated that the Company also is considering adopting an equity compensation plan, which would be used only to grant awards to individuals as inducements material to their entering into employment with the company (the “Inducement Plan”). You stated that all awards made under this plan would satisfy the requirements of Listing Rule 5635(c)(4). You further stated that the Company has hired new employees pursuant to offer letters that describe equity grants to be made to the new employees if they accept employment with the Company, but that the grants described in those offer letters have not yet been made (the “Prior Inducement Awards”). You also indicated that the Prior Inducement Awards meet all of the requirements of Listing Rule 5635(c)(4). You asked whether the Prior Inducement Awards could be made under the newly adopted Inducement Plan.
Following our review of the information you provided, we have determined that the Company may issue the Prior Inducement Awards under the newly adopted Inducement Plan without obtaining shareholder approval for the awards or the plan. We have reached this conclusion because, under the Rule, Inducement Awards do not require shareholder approval and the Rule does not prescribe any specific administrative aspects for an Inducement Plan, such as the timing of its adoption. Please note that pursuant to Listing Rule 5635(c)(4), inducement awards must be material to the recipient entering into employment with the company, must be approved by either the issuer's independent compensation committee or a majority of the issuer's independent directors, and, promptly following an issuance of any inducement awards, the company must disclose in a press release the material terms of the grant, including the recipient(s) of the grant and the number of shares involved.
|
Publication Date*:
1/13/2022
|
|
|
Identification Number:
1856
|
|
|
|
|
Identification Number
1807
|
|
|
This is in response to your correspondence asking if the Company may satisfy the disclosure requirements set forth in Listing Rule 5635(c)(4) (the “Rule”) related to the exception to the shareholder approval requirement for equity awards issued to certain new employees by issuing a press release disclosing the material terms of the inducement grant prior to the grant’s date.
The Company intends to grant equity awards to employees of certain businesses that the Company is acquiring (the “Acquisitions”), in each case as an inducement material to such employees entering into employment with the Company upon the closing of the Acquisitions (the “Inducement Awards”). The Company’s compensation committee approved the Inducement Awards and the terms of the Inducement Awards will be communicated to employees prior to the closing date of the Acquisitions.
You stated that for administrative reasons, the Inducement Awards will not be granted until approximately three months following the closing date of the Acquisitions. You further stated that such a delay is due to the Company’s preexisting policy of processing equity grants on a quarterly basis rather than on a rolling basis. Pursuant to this policy the Inducement Awards will be issued on the nearest scheduled grant date. You indicated that all material terms of the Inducement Awards will be determined prior the closing date of the Acquisitions and such terms, including the number of shares underlying the Inducement Awards and their vesting schedule, will not be impacted by the delay. There are no material conditions that grantees must satisfy after closing in order to receive an Inducement Award.
You indicated that the Company intends to issue a press release describing the Inducement Awards on the closing date of the Acquisitions, which will be after all material terms are determined and disclosed to the recipients, but before the grant date of the Inducement Awards. You confirmed that, given that the press release will be issued before the Inducement Awards are granted, if there is a subsequent material change with respect to the Inducement Awards, the Company would issue another press release updating the facts of the original press release.
Following our review of the information you provided we have determined that the administrative delay in issuing the Inducement Awards does not preclude the availability of the inducement grant exception under the Rule because the terms of the Inducement Awards will be determined and communicated to the grantees prior to the individual's entering into employment with the Company and such terms, including the number of shares underlying the Inducement Awards, will not be impacted by the delay. Furthermore, we have determined that the Company may disclose the material terms of the Inducement Awards prior to the actual grant date, but after all material terms have been determined, provided that the Company must issue a clarifying press release “[p]romptly following an issuance” of the Inducement Awards, as required by the Rule, if there is any subsequent material change with respect to the Inducement Awards.
|
Publication Date*:
9/3/2021
|
|
|
Identification Number:
1807
|
|
|
|
|
Identification Number
1793
|
|
|
This is in response to your correspondence asking if the establishment of an omnibus incentive plan in order to consolidate the Company’s three incentive plans would be considered a material amendment and, as a result, require shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”).
The Cash Plan allows cash awards only and does not provide for the issuance of equity securities. The Stock Plan and the Stock Option Plan are equity compensation plans, which required shareholder approval under the Listing Rules and were approved by the shareholders. The Stock Plan provides for restricted stock awards for directors, officers and employees. The Stock Option Plan provides for grants of certain stock options for directors, officers, employees and consultants.
You stated that the Company is contemplating consolidating these three incentive plans by the establishment of an omnibus incentive plan (the “Omnibus Plan”) that would serve as an “umbrella” over these plans, with each plan maintaining its original purpose and material terms. You stated that the consolidation of the plans would allow the Company to align defined terms and other common features of these plans and to streamline the administration of its incentive compensation program.
You further stated that the Company expects that these plans would function as sub-plans within the Omnibus Plan and the number of shares approved for issuance for the Stock Plan and the Stock Option Plan would remain unchanged. You also stated that the Company does not intend to take any action that would have the effect of providing any material increase in benefits to participants. In that regard, the duration of each plan would not be extended and would remain as currently provided for under each plan.
You stated that although the class of participants eligible to receive awards under each plan are distinct, the Company does not intend to broaden eligibility across the plans or make any new class of participants under the Omnibus Plan eligible for a type of award for which they were not previously eligible under each plan. Specifically, consultants are only eligible to receive awards under the Stock Option Plan and, after the consolidation, stock options under the Stock Option Plan would still be the only type of award consultants are eligible to receive under the Omnibus Plan.
Following our review of the information provided, we have determined that the Company’s actions to consolidate these plans under the Omnibus Plan would not be a material amendment for purposes of the Rule. While under the Omnibus Plan certain terms and features of the plans will be amended, there will be no increase in the maximum number of shares to be issued under the plans. As such, the establishment of the Omnibus Plan will not increase the overall dilution possible under the plans. The establishment of the Omnibus Plan is not intended to and does not result in any material increase in benefits to the participants. The Amendment also does not result in any material expansion in the class of participants eligible to participate in the Omnibus Plan because these plans would function as sub-plans within the Omnibus Plan and the participants under the Omnibus Plan are eligible only for a type of award for which they were previously eligible under each plan. Finally, the consolidation of the plans does not result in any expansion in the types of awards provided under these plans.
|
Publication Date*:
6/25/2021
|
|
|
Identification Number:
1793
|
|
|
|
|
Identification Number
1779
|
|
|
This is in response to your correspondence asking if an amendment modifying the applicability of the annual limit for certain awards (the “Amendment”) issuable under a shareholder approved Equity Plan would be considered a material amendment and, as a result, require shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”).
The Equity Plan is an equity compensation plan, which required shareholder approval under the Listing Rules and was approved by the shareholders. The Equity Plan provides for grants of a variety of stock-based awards including options, stock appreciation rights and restricted share awards to employees, consultants and directors of the Company.
You stated that the Equity Plan establishes an Annual Value Limit, which is the maximum value that can be granted to any director of shares of common stock subject to awards granted during a single fiscal year, together with any cash fees paid to such director during the fiscal year. You further stated that the compensation committee of the Company’s board of directors determined that it was in the best interest of the Company and its stockholders to include a “meaningful limit” in the Equity Plan on the compensation of directors for their service on the board, which has become a widely accepted best practice for Delaware corporations.
You stated that the Annual Value Limit was meant to be applicable only to the non-employee directors rather than all directors and that the difference was a result of a scrivener’s error. You also point to disclosure in the Company’s proxy seeking approval of the Equity Plan that is consistent with this view. The Amendment will modify the Equity Plan making the Annual Value Limit applicable only to the non-employee directors.
Following our review of the information provided, we have determined that the Amendment would not be a material amendment for purposes of the Rule. While the Amendment changes the applicability of the Annual Value Limit, there will be no increase in the maximum number of shares to be issued under the Equity Plan. As such, the Amendment may affect the timing of when certain awards could be made, but it will not increase the overall dilution possible under the Equity Plan, and therefore does not result in any material increase in benefits to the participants. The Amendment also does not result in any material expansion in the class of participants eligible to participate in the Equity Plan. Finally, the Amendment does not result in any expansion in the types of awards provided under the Equity Plan.
|
Publication Date*:
12/15/2020
|
|
|
Identification Number:
1779
|
|
|
|
|
Identification Number
1718
|
|
|
This is in response to your correspondence asking if an amendment to a shareholder approved Equity Plan removing the annual limit on issuing certain awards to a single individual (the “Amendment”) would be considered a material amendment and, as a result, require shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”). The annual limits were initially included to comply with an exemption under Section 162(m) of the Internal Revenue Code of 1986, as amended (the “Code”), for certain qualified performance-based compensation that was removed in the Tax Cuts and Jobs Act of 2017.
The Equity Plan is an equity compensation plan, which required shareholder approval under the Listing Rules and was approved by the shareholders. The Equity Plan provides for grants of a variety of stock-based awards including options, stock appreciation rights, restricted stock units, restricted stock and performance shares to officers, employees, and directors of the Company.
You stated that the Equity Plan establishes a maximum number of shares of common stock that can be issued under the Equity Plan. You further stated the Equity Plan imposes a maximum number of shares that may be granted in the form of stock options or stock appreciation rights to any one individual during any one calendar year period (the “Annual Limit”). Finally, the Equity Plan establishes a maximum number of shares of common stock underlying awards that may be granted to any one employee (the “Lifetime Individual Limit”).
Section 162(m) of the Code, generally, imposed a $1 million cap on a publicly-traded corporation's federal income tax deduction for compensation paid to certain “Covered Employees” as defined in the Code. However, the Code provided for a "qualified performance-based compensation" exception (the “QPBC Exception”), which exempted certain qualified performance-based compensation from the $1 million deduction limitation under Section 162(m) if specified requirements were satisfied. You stated that the Company included the Annual Limit in the Equity Plan to ensure that stock options granted under the Equity Plan to a Covered Employee would qualify for the QPBC Exception.
The Tax Cuts and Jobs Act of 2017, which was signed into law on December 22, 2017, eliminated the QPBC Exception under Section 162(m). As a result, you stated that there is no longer any legal rationale for the Equity Plan to include the Annual Limit and that the Company is therefore proposing the Amendment.
Following our review of the information provided, we have determined that the Amendment would not be a material amendment for purposes of the Rule. While the Amendment deletes the Annual Limit, there will be no increase to the maximum number of shares to be issued under the Equity Plan. As such, the Amendment may affect the timing of when certain awards could be made, but it will not increase the overall dilution possible under the Equity Plan. Furthermore, the Amendment does not result in any material increase in benefits to the participants because the Amendment does not change the Lifetime Individual Limit, or any material expansion in the class of participants eligible to participate in the Equity Plan. Finally, the Amendment does not result in any expansion in the types of awards provided under the Equity Plan.
|
Publication Date*:
10/30/2019
|
|
|
Identification Number:
1718
|
|
|
|
|
Identification Number
1140
|
|
|
This is in response to your correspondence asking if an amendment to a shareholder approved employee stock purchase plan (the “ESPP”) changing certain purchase limitations would be considered a material amendment and, as a result, require shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”).
You stated that the Company has an ESPP that does not satisfy the tax qualification requirement of Section 423 of the Internal Revenue Code because only certain employees of the Company are eligible to participate, and as a result, is an equity compensation plan that requires shareholder approval under the Listing Rules. The ESPP provides an eligible participant (“Participant”) the opportunity to purchase shares of Company common stock on a quarterly basis (the “Offering Period”), subject to certain limits. In a single Offering Period, a Participant is allowed to purchase shares of common stock subject up to a maximum number of shares and the percentage of compensation that a participant may use to purchase shares is capped. The ESPP also contains a calendar year limitation on total payroll deductions.
You stated that the Company is proposing two changes to the ESPP (together, the “Amendment”). First, the Company proposes to reduce the maximum percentage of a Participant’s compensation that may be used to purchase shares during each Offering Period. Second, the Company proposes to increase the maximum dollar amount a Participant may spend to purchase shares during a calendar year. You stated that the proposed Amendment would not increase the maximum number of shares a Participant may purchase during an Offering Period and would not increase the total number of shares authorized and available for purchase under the ESPP.
Following our review of the information you provided, we have determined that the Amendment would not be a material amendment for purposes of the Rule. While the Amendment changes certain purchase limitations, there will be no increase in the maximum number of shares to be issued under the ESPP. As such, while the Amendment may affect the timing of when certain awards could be made, it will not increase the overall dilution possible under the ESPP. Furthermore, the Amendment does not result in any material increase in benefits to the Participants or any material expansion in the class of participants eligible to participate in the ESPP. Finally, the Amendment does not result in any expansion in the types of awards provided under the ESPP.
|
Publication Date*:
12/2/2015
|
|
|
Identification Number:
1140
|
|
|
|
|
Identification Number
1137
|
|
|
This is in response to your correspondence regarding the application of Nasdaq’s shareholder approval rules to certain equity grants. You asked if the Company may rely upon the exception set forth in Listing Rule 5635(c)(4) (the “Rule”) to the shareholder approval requirement for equity grants made in connection with the appointment of a director of a Company subsidiary as an executive officer of the Company.
The Company has a majority owned subsidiary, a master limited partnership (the “Subsidiary”), whose general partner (the “GP”) is an indirect wholly-owned subsidiary of the Company. The Subsidiary is listed and publicly traded on a U.S. stock exchange. You stated that, in connection with consideration by the Company’s board of directors of a potential change in management, the board approached a director of the GP to assess that individual’s interest in becoming an executive officer of the Company (the “New Executive Officer”). The board of directors of the GP has determined that the director is an independent director under the rules of the exchange where the Subsidiary is listed. Shortly thereafter, the Company and the New Executive Officer agreed to a framework for compensation, subject to final documentation prepared with the assistance of the Company’s compensation committee. You further stated that the agreed-upon compensation structure included the issuance of options and performance stock units. You asked whether the fact that the New Executive Officer is an independent director of the Subsidiary precludes the availability of the “inducement” grant exception under the Rule.
Following our review of the information provided, and subject to the disclosure requirements in the Rule, we determined that the New Executive Officer’s role as an independent director of the Subsidiary does not preclude the availability of the “inducement” grant exception under the Rule. Our determination is based on facts as you described them to us, including that the New Executive Officer was neither an employee nor a director of the Company and that the agreed-upon compensation structure included equity grant(s) to the New Executive Officer.
|
Publication Date*:
3/16/2015
|
|
|
Identification Number:
1137
|
|
|
|
|
Identification Number
1132
|
|
|
This is in response to your correspondence asking if an amendment to a shareholder approved equity compensation plan to permit the accrual of cash dividend equivalents for restricted stock units (“RSUs”) would be considered a material amendment requiring shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”).
You stated that the Company currently has a shareholder-approved equity compensation plan (the “Plan”) that allows for grants of restricted stock, which may accrue dividends during vesting, and of RSUs, which do not accrue dividends. The Company proposes to amend the Plan to allow for the accrual of cash dividend equivalents with respect to the RSUs. The cash dividend equivalents would not vest until the underlying RSUs vest, and would be payable in cash. You stated that the holders of the RSUs would not be able to elect to receive common stock or stock units in lieu of the cash payment. You stated that there would be no other changes to the Plan and the proposed amendment would not either require or permit the issuance of additional shares under the Plan.
Following our review of the information provided, including that the proposed amendment you described would not necessitate the issuance of any shares under the Plan, we have determined that it would not be material for purposes of the Rule and, accordingly, would not require shareholder approval under the Rule.
|
Publication Date*:
11/12/2014
|
|
|
Identification Number:
1132
|
|
|
|
|
Identification Number
1130
|
|
|
This is in response to your correspondence requesting an exception under Listing Rule 5635(f) from Nasdaq’s shareholder approval requirements with respect to the proposed issuance of securities (the “Proposed Transaction”).
You have stated that since its inception, the Company has recorded net losses in every fiscal year but one. Additionally, in the most recent annual report on Form 10-K, the Company’s independent auditor includes the qualification that there is substantial doubt concerning the Company’s ability to continue as a going concern. You have stated that, without the Proposed Transaction, the Company has only enough cash to fund operations for the next four weeks.
In the Proposed Transaction, the Company will issue units consisting of common stock and convertible preferred stock (the “Preferred Stock”). The purchase price would be at a discount to the current market value of the units (when such value is determined by adding the current market values of the common stock shares issued as part of the units and common stock shares to be issued upon a future conversion of the Preferred Stock shares issued as part of the units).
You stated that investors in the Proposed Transaction would include officers and directors, as well as current and new shareholders of the Company (the “Proposed Investors”). Following completion of the Proposed Transaction and subject to conversion of the Preferred Stock, the Proposed Investors would own greater than 50% of the outstanding common stock shares, with the largest shareholder owning more than 20% of the outstanding common stock shares. The common stock shares issued or issuable as a result of the Proposed Transaction will represent more than 20% of the pre-transaction total number of outstanding common stock shares.
You stated that the Company has pursued multiple alternative financing strategies for over one year, including the potential sale of the Company, and that there are no realistic alternatives to the Proposed Transaction. You stated that if the Proposed Transaction is not completed in the very near term, the Company would be forced to cease operations and terminate most employees, and that the Company’s assets would be liquidated through an assignment for the benefit of creditors or through a bankruptcy process. You stated that there can be no assurance that any liquidation proceeds would remain for distribution to the Company’s shareholders. Finally, you stated that the Company expects that the Proposed Transaction would enable the Company to meet the requirements for continued listing on Nasdaq for at least the next year.
Without the requested exception, shareholder approval may be required pursuant to each of the following rules: Listing Rule 5635(b), because one of the Proposed Investors would own more than 20% of the shares of common stock outstanding upon completion of the Proposed Transaction; Listing Rule 5635(c), because the issuance at a discount of common stock shares to the officers and directors constitutes equity compensation; and Listing Rule 5635(d), because common stock shares issued or issuable as a result of the Proposed Transaction at a price less than the greater of book or market value would represent more than 20% of the pre-transaction number of outstanding common stock shares.
Based on our review of the circumstances described in your correspondence and on your representations regarding the Company’s financial condition, we have determined to grant the requested exception to the shareholder approval rules. This determination is based upon your representations that the Company needs to quickly proceed with the Proposed Transaction to avoid the ceasing of operations. In order to rely upon this exception, the Company must mail to all shareholders, not later than ten days before the issuance of any securities, a letter describing the Proposed Transaction (including the number of shares of common stock that could be issued and the consideration to be received) and alerting shareholders to the omission to seek their otherwise required approval. The letter must indicate that the Company is relying on a financial viability exception to the shareholder approval rules and that the audit committee, or a comparable independent body of the board of directors, has expressly approved reliance on this exception. The Company must also make a public announcement by filing a Form 8-K, where required by rules of the SEC, or by issuing a press release, disclosing the same information as required in the letter as promptly as possible but not later than ten days before the issuance of the securities.
|
Publication Date*:
10/7/2014
|
|
|
Identification Number:
1130
|
|
|
|
|
Identification Number
1111
|
|
|
This is in response to your correspondence regarding the effect of a planned business combination between the company and the Target (the “Business Combination”) under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”). You asked whether grants from the company’s existing equity plans would require shareholder approval under the Rule after the Business Combination is completed.
In the Business Combination, a holding company (“HoldCo”) will be formed and the company and the Target will each merge into separate newly created subsidiaries of HoldCo. The company’s shareholders will receive one newly issued HoldCo ordinary share for each company share owned, and the Target’s shareholders will receive a number of Holdco ordinary shares for each Target share owned that would result in the Target shareholders owning X percent of HoldCo. You stated that the company’s President/Chief Executive Officer will become the Chief Executive Officer of Holdco and that the company’s Chief Financial Officer will become the Chief Financial Officer of HoldCo. Additionally, you stated that the company will be considered the acquirer for accounting purposes under U.S. GAPP. Upon closing you stated that you expect HoldCo will be listed on the NASDAQ Stock Market, where the company is now listed, and a foreign market, where the Target is now listed.
You indicated that the company currently maintains the Incentive Plan, which is a shareholder approved plan that provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance units and performance shares to service providers of the company and certain related entities, and both the U.S. ESPP and the Offshore ESPP, which allow U.S. and non-U.S. employees, respectively, to purchase the company’s equity. The outstanding awards under each Plan will be assumed by HoldCo and adjusted by the exchange ratio of 1:1, and therefore, the number of shares subject to such awards and the exercise price will remain the same.
Following our review of the information provided, we have concluded that the Business Combination will be treated as a substitution listing event under Listing Rule 5250(e)(4). We have reached this conclusion because the company’s shareholders will own substantially more than 50% of the HoldCo’s shares following the Business Combination, and it is supported by the fact that the company’s CEO and CFO will maintain those roles at HoldCo and by your representation that the company will be considered the acquirer in the transaction under U.S. GAAP. As such, HoldCo may assume the company’s Incentive Plan without any restrictions on future grants or awards to the eligible participants of HoldCo under the Incentive Plan. Furthermore, since the U.S. ESPP is designed to satisfy the requirements of Section 423, and the Offshore ESPP is a plan that provides non-U.S. employees with the substantially the same benefits as the U.S. ESPP, HoldCo may assume both the U.S. ESPP and the Offshore ESPP without shareholder approval under the Rule.
|
Publication Date*:
3/5/2014
|
|
|
Identification Number:
1111
|
|
|
|
|
Identification Number
1110
|
|
|
This is in response to your correspondence asking whether a proposed amendment to the company’s Equity Plan (the “Amendment”) would be considered a material amendment requiring shareholder approval under Listing Rule 5635(c) (the “Rule”).
The Equity Plan, which was established prior to the company’s listing on the NASDAQ Stock Market, contains an annual award limit of 500,000 shares per person (the “Limit”). You indicated that the Limit is a plan feature used to preserve the deductibility of compensation to certain employees. You indicated that the company interprets the Equity Plan to require the Limit to be adjusted proportionately for certain changes in the company’s capitalization, including, but not limited to, a reverse stock split.
Just prior to listing, the company effected a one-for-five reverse stock split and, as a result, the Limit was adjusted proportionately downward to 100,000 shares. According to the information you provided, the Amendment would restore the Limit to 500,000 shares. The Amendment would not prevent other adjustments to the Limit due to future changes to the company’s capitalization, including future reverse stock splits. You stated that the Amendment will not result in any increase in the total number of shares available for issuance under the Equity Plan.
Following our review of the information provided, we have determined that the Amendment would not be a material amendment for purposes of the Rule. While the Amendment increases the Limit, there will be no increase to the maximum number of shares to be issued under the Equity Plan. As such, while the Amendment may affect the timing of when certain awards could be made, it will not increase the overall dilution possible under the Equity Plan. Furthermore, the Amendment does not result in any material increase in benefits to the participants or any material expansion in the class of participants eligible to participate in the plan. Finally, the Amendment does not result in any expansion in the types of awards provided under the Equity Plan.
|
Publication Date*:
3/5/2014
|
|
|
Identification Number:
1110
|
|
|
|
|
Identification Number
1090
|
|
|
This is in response to your correspondence regarding whether certain proposed actions in connection with the payment by the Company of an extraordinary cash dividend would be considered material amendments to the Company's equity compensation plans, requiring shareholder approval under Listing Rule 5635(c) and IM-5635-1 (collectively, the “Rule”). You indicated that the Company is considering paying an extraordinary cash dividend, which would equal approximately 25% of the Company's current stock price.
Under the Company's stock plans (the “Stock Plans”), the Company currently has outstanding stock options, stocks appreciation rights (“SARs”), and restricted stock units (“RSUs”) (collectively, the “Awards”). The Company also maintains an ESPP, which is designed to qualify under Section 423 of the Internal Revenue Code of 1986, as amended.
The Company proposes to amend the Stock Plans to allow for adjustments of the Awards upon the payment of an extraordinary cash dividend by the Company (the “Plan Amendments”). Under the Plan Amendments, the Company would make a cash payment upon vesting of an outstanding RSU in an amount equal to the amount of the extraordinary cash dividend. Adjustments to options and SARs would vary based on the tax effect of the adjustment to the recipient. Wherever permissible under guidance issued by the IRS, the Company would reduce the exercise price of the option or SAR by the amount of the extraordinary dividend (the “Exercise Price Adjustment”). However, you stated that under this IRS guidance, where the post-adjusted exercise price of a stock option or SAR would be equal to or less than 30% of the underlying stock price immediately following the adjustment, the IRS would recharacterize the award, resulting in a change in the Award's tax status to the recipient. In these cases, the Company would reduce the Award's exercise price to the extent permissible under the IRS guidance without a change in the recipient's tax status (the “Partial Adjustment”). In addition, the Company will make a cash payment to the recipient in an amount equal to the difference between the amount of the extraordinary cash dividend and the Partial Adjustment. The Plan Amendments would be approved by the independent compensation committee of the Company's board of directors.
The Company also proposes to amend the ESPP to preserve the existing intrinsic value through a proportionate adjustment to the number of shares and purchase price for shares purchasable during the ESPP offering period when an extraordinary cash dividend is paid (the “ESPP Amendments”). The ESPP Amendments would be approved by the independent compensation committee of the Company's board of directors. You have represented that implementing the ESPP Amendments as proposed without shareholder approval would not affect the treatment of the ESPP under Section 423 of the Internal Revenue Code.
Following our review of the information provided, we have determined that the Plan Amendments you described would not be material amendments for purposes of the Rule. We note that the proposed Plan Amendments to provide cash payments to affected participants in the Plans are not subject to the Rule, which only applies to equity compensation. Further, reducing the exercise price of the outstanding stock options and SARs would not increase the intrinsic value of the Awards and such reduction would not provide any additional benefit to the recipients, other than that one-time adjustment to reflect the extraordinary dividend. Therefore, the Exercise Price Adjustment and Partial Adjustment would not result in a material increase in the benefits to the participants. In addition, the Plan Amendments would not result in: a material expansion in the class of participants; a material increase in the number of shares to be issued under the Stock Plans; or an expansion in the types of awards available. As a result, shareholder approval is not required for the Plan Amendments under the Rule.
Under Listing Rule 5635(c)(2) , shareholder approval is not required for the adoption or amendment of a tax qualified, non-discriminatory employee benefit plan, including a plan that meets the requirements of Section 423 of the Internal Revenue Code, if such plans are approved by a company's independent compensation committee. Since the ESPP and the ESPP Amendments are designed to satisfy the requirements of Section 423, and the ESPP Amendments will only be implemented with approval of the Company's independent compensation committee, shareholder approval is not required for the ESPP Amendments.
|
Publication Date*:
8/29/2013
|
|
|
Identification Number:
1090
|
|
|
|
|
Identification Number
1080
|
|
|
This is in response to your correspondence regarding whether the proposed amendments to outstanding options and warrants would be considered a material amendment requiring shareholder approval under Listing Rule 5635(c) (the “Rule”).
Prior to the Company's listing on NASDAQ, the Company's subsidiary sold units consisting of one share of common stock and one warrant to purchase additional shares of common stock to certain of its officers, a non-executive employee and current and former directors. Separately, following a holding company reorganization, the Company sold warrants at fair market value based on the Black-Scholes valuation model to certain members of senior management and to certain directors. Finally, the Company issued options to purchase common stock under a shareholder approved equity plan (“Equity Plan”) to two non-executive employees. The warrants and options, which are not publicly traded, are exercisable into the Company's listed common stock and are owned by current or former officers, non-executive employees and directors of the Company or the subsidiary.
The Company is proposing to amend the terms of the warrants and the Equity Plan to allow for the adjustment of the exercise price of the warrants and options upon the distribution of an extraordinary cash dividend by the Company (the “Amendments”). Any adjustment under the Amendments would be at the discretion of a committee of the board of directors, provided, however, that no adjustment could increase the intrinsic value of a warrant or option as measured before the ex-dividend date of the extraordinary cash dividend.
Following our review of the information provided, we have determined that the Amendments you described would not be a material amendment for purposes of the Rule. In that regard, we note that the proposed Amendments would not increase the intrinsic value of a warrant or option and, therefore, would not result in an increase in the benefits to the participants. In addition, the Amendments would not result in: a material expansion in the class of participants; an increase in the number of shares to be issued under the Equity Plan or upon exercise of the warrants; or an expansion in the types of awards available. As a result, shareholder approval is not required for the Amendments under the Rule.
|
Publication Date*:
5/20/2013
|
|
|
Identification Number:
1080
|
|
|
|
|
Identification Number
1061
|
|
|
This is in response to your correspondence regarding whether a proposed amendment to the terms of the Preferred Units (the “Amendment”) would require shareholder approval as equity compensation to the Director under Listing Rule 5615(a)(4)(H) (the “Rule”). The Company is a limited partnership with its common units listed on NASDAQ. The Preferred Units, which are not publicly traded, are convertible into the listed common units on a one-for-one basis.
Following the issuance of the Preferred Units to the Investor nearly two years ago, the Director, an affiliate of the Investor, joined the board of directors of the general partner of the Company. Prior to the issuance, neither the Director nor the Investor was affiliated with the company.
Currently, the Company is permitted to pay quarterly distributions on the Preferred Units in cash or by issuing additional Preferred Units as payment-in-kind (the “PIK Distributions”). Pursuant to the Amendment, the quarterly distributions would be payable only as PIK Distributions through the end of next year. Currently, the original issuance price of the Preferred Units is used to calculate the number of Preferred Units issuable as PIK Distributions. As such, the number of Preferred Units issuable as PIK Distributions is equal to the total dollar amount of the distributions divided by the original purchase price. The current market price of the Company’s common units is greater than the original issuance price of the Preferred Units.
Under the Amendment, instead of being based on the original issuance price, the PIK Distributions would be based on a fixed price equal to an approximate 10% discount to the current market price of the common units subject to a maximum and minimum threshold (“the Amended PIK Price”). The Amended PIK Price would be capped at an amount which would be approximately 59% greater than the original issuance price, and would not be less than the original issuance price. Thus, the Amendment could potentially increase, but could not reduce, the price applicable to the PIK Distributions and, correspondingly, could reduce the number of Preferred Units issued as PIK Distributions. The Amendment would not change the minimum aggregate dollar amount of the quarterly distributions.
Because it would pay quarterly distributions as PIK Distributions rather than in cash, the Company would achieve its purpose of having additional funds available for capital expenditures. Likewise, the Investor would achieve its purpose of increasing its equity stake in the Company.
Following our review of the information that you provided, we have determined that the Amendment would not be material for purposes of the Rule and, therefore, would not require shareholder approval as equity compensation. We have reached the conclusion because the Amendment could potentially increase, but could not decrease, the price used to calculate the number of units to be issued with respect to PIK Distributions, and would not result in an increase in benefits available to the Investor. In addition, the Amendment could reduce the number of Preferred Units issuable as PIK Distributions, resulting in fewer common units being issuable upon conversion.
|
Publication Date*:
11/30/2012
|
|
|
Identification Number:
1061
|
|
|
|
|